Theranos, the health technology and medical laboratory services company in Palo Alto, California, has already had a slew of problems this year. It’s currently under investigation by the Securities and Exchange Commission and has plans to lay off 340 employees after announcing that it will close laboratories and wellness centers in Arizona, California and Pennsylvania.

St. Jude Medical issued an advisory Oct. 11 warning of premature battery depletion associated with lithium deposits in a small number of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ICDs.

Theranos founder and CEO Elizabeth Holmes announced on Oct. 5 that the blood testing company would close its laboratories and wellness centers in Arizona, California and Pennsylvania.

The University of Kentucky filed a lawsuit against the Lexington Herald-Leader newspaper to avoid revealing information on a failed deal between the university and a cardiology company, the Herald-Leader reports.

AstraZeneca announced on Oct. 4 that patients with symptomatic peripheral artery disease who took ticagrelor (Brilinta) did not have better outcomes than those who received clopidogrel, a rival blood thinner.

Accountable care organizations (ACOs) should play a major role for the cardiac care bundled payments model that the Centers for Medicare & Medicaid Services (CMS) proposed in July, according to the American Group Medical Association (AMGA).

Eight medical organizations, antitobacco groups and three pediatricians filed a federal lawsuit on Oct. 4 against the U.S. Food and Drug Administration (FDA). They want the agency to enforce The Tobacco Control Act and issue a final rule requiring graphic health warnings on cigarette packs and advertising.

For the second time in less than a month, Aralez Pharmaceuticals has struck a deal with a major pharmaceuticals company for a cardiovascular medication.